ID   ALG8_HUMAN              Reviewed;         526 AA.
AC   Q9BVK2; A6NDW6; O60860;
DT   27-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT   03-APR-2007, sequence version 2.
DT   15-MAR-2017, entry version 149.
DE   RecName: Full=Probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase;
DE            EC=2.4.1.265;
DE   AltName: Full=Asparagine-linked glycosylation protein 8 homolog;
DE   AltName: Full=Dol-P-Glc:Glc(1)Man(9)GlcNAc(2)-PP-dolichyl alpha-1,3-glucosyltransferase;
DE   AltName: Full=Dolichyl-P-Glc:Glc1Man9GlcNAc2-PP-dolichyl glucosyltransferase;
GN   Name=ALG8; ORFNames=HUSSY-02;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT SER-222.
RC   TISSUE=Melanocyte;
RX   PubMed=11124703;
RX   DOI=10.1002/1097-0061(200101)18:1<69::AID-YEA647>3.0.CO;2-H;
RA   Stanchi F., Bertocco E., Toppo S., Dioguardi R., Simionati B.,
RA   Cannata N., Zimbello R., Lanfranchi G., Valle G.;
RT   "Characterization of 16 novel human genes showing high similarity to
RT   yeast sequences.";
RL   Yeast 18:69-80(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   INVOLVEMENT IN CONGENITAL DISORDER OF GLYCOSYLATION TYPE I.
RX   PubMed=12480927; DOI=10.1074/jbc.M211950200;
RA   Chantret I., Dancourt J., Dupre T., Delenda C., Bucher S.,
RA   Vuillaumier-Barrot S., Ogier de Baulny H., Peletan C., Danos O.,
RA   Seta N., Durand G., Oriol R., Codogno P., Moore S.E.H.;
RT   "A deficiency in dolichyl-P-glucose:Glc1Man9GlcNAc2-PP-dolichyl
RT   alpha3-glucosyltransferase defines a new subtype of congenital
RT   disorders of glycosylation.";
RL   J. Biol. Chem. 278:9962-9971(2003).
RN   [6]
RP   VARIANTS CDG1H PRO-47 AND ASP-275, AND VARIANT SER-222.
RX   PubMed=15235028; DOI=10.1136/jmg.2003.016923;
RA   Schollen E., Frank C.G., Keldermans L., Reyntjens R., Grubenmann C.E.,
RA   Clayton P.T., Winchester B.G., Smeitink J., Wevers R.A., Aebi M.,
RA   Hennet T., Matthijs G.;
RT   "Clinical and molecular features of three patients with congenital
RT   disorders of glycosylation type Ih (CDG-Ih) (ALG8 deficiency).";
RL   J. Med. Genet. 41:550-556(2004).
CC   -!- FUNCTION: Adds the second glucose residue to the lipid-linked
CC       oligosaccharide precursor for N-linked glycosylation. Transfers
CC       glucose from dolichyl phosphate glucose (Dol-P-Glc) onto the
CC       lipid-linked oligosaccharide Glc(1)Man(9)GlcNAc(2)-PP-Dol (By
CC       similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: Dolichyl beta-D-glucosyl phosphate + D-Glc-
CC       alpha-(1->3)-D-Man-alpha-(1->2)-D-Man-alpha-(1->2)-D-Man-alpha-
CC       (1->3)-[D-Man-alpha-(1->2)-D-Man-alpha-(1->3)-(D-Man-alpha-(1->2)-
CC       D-Man-alpha-(1->6))-D-Man-alpha-(1->6)]-D-Man-beta-(1->4)-D-
CC       GlcNAc-beta-(1->4)-D-GlcNAc-diphosphodolichol = D-Glc-alpha-
CC       (1->3)-D-Glc-alpha-(1->3)-D-Man-alpha-(1->2)-D-Man-alpha-(1->2)-D-
CC       Man-alpha-(1->3)-[D-Man-alpha-(1->2)-D-Man-alpha-(1->3)-(D-Man-
CC       alpha-(1->2)-D-Man-alpha-(1->6))-D-Man-alpha-(1->6)]-D-Man-beta-
CC       (1->4)-D-GlcNAc-beta-(1->4)-D-GlcNAc-diphosphodolichol + dolichyl
CC       phosphate.
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- INTERACTION:
CC       O43889-2:CREB3; NbExp=3; IntAct=EBI-3921603, EBI-625022;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9BVK2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BVK2-2; Sequence=VSP_046291;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Congenital disorder of glycosylation 1H (CDG1H)
CC       [MIM:608104]: A form of congenital disorder of glycosylation, a
CC       multisystem disorder caused by a defect in glycoprotein
CC       biosynthesis and characterized by under-glycosylated serum
CC       glycoproteins. Congenital disorders of glycosylation result in a
CC       wide variety of clinical features, such as defects in the nervous
CC       system development, psychomotor retardation, dysmorphic features,
CC       hypotonia, coagulation disorders, and immunodeficiency. The broad
CC       spectrum of features reflects the critical role of N-glycoproteins
CC       during embryonic development, differentiation, and maintenance of
CC       cell functions. {ECO:0000269|PubMed:15235028}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the ALG6/ALG8 glucosyltransferase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA12176.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ224875; CAA12176.1; ALT_INIT; mRNA.
DR   EMBL; AP002520; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471076; EAW75050.1; -; Genomic_DNA.
DR   EMBL; BC001133; AAH01133.1; -; mRNA.
DR   CCDS; CCDS41692.1; -. [Q9BVK2-2]
DR   CCDS; CCDS8258.1; -. [Q9BVK2-1]
DR   RefSeq; NP_001007028.1; NM_001007027.2. [Q9BVK2-2]
DR   RefSeq; NP_076984.2; NM_024079.4. [Q9BVK2-1]
DR   UniGene; Hs.503368; -.
DR   ProteinModelPortal; Q9BVK2; -.
DR   BioGrid; 122511; 27.
DR   IntAct; Q9BVK2; 6.
DR   STRING; 9606.ENSP00000299626; -.
DR   CAZy; GT57; Glycosyltransferase Family 57.
DR   iPTMnet; Q9BVK2; -.
DR   PhosphoSitePlus; Q9BVK2; -.
DR   BioMuta; ALG8; -.
DR   DMDM; 143811361; -.
DR   EPD; Q9BVK2; -.
DR   MaxQB; Q9BVK2; -.
DR   PaxDb; Q9BVK2; -.
DR   PeptideAtlas; Q9BVK2; -.
DR   PRIDE; Q9BVK2; -.
DR   DNASU; 79053; -.
DR   Ensembl; ENST00000299626; ENSP00000299626; ENSG00000159063. [Q9BVK2-1]
DR   Ensembl; ENST00000376156; ENSP00000365326; ENSG00000159063. [Q9BVK2-2]
DR   Ensembl; ENST00000615266; ENSP00000480742; ENSG00000159063. [Q9BVK2-2]
DR   GeneID; 79053; -.
DR   KEGG; hsa:79053; -.
DR   UCSC; uc001oyz.2; human. [Q9BVK2-1]
DR   CTD; 79053; -.
DR   DisGeNET; 79053; -.
DR   GeneCards; ALG8; -.
DR   GeneReviews; ALG8; -.
DR   HGNC; HGNC:23161; ALG8.
DR   HPA; HPA051898; -.
DR   MalaCards; ALG8; -.
DR   MIM; 608103; gene.
DR   MIM; 608104; phenotype.
DR   neXtProt; NX_Q9BVK2; -.
DR   OpenTargets; ENSG00000159063; -.
DR   Orphanet; 79325; ALG8-CDG.
DR   PharmGKB; PA134942124; -.
DR   eggNOG; KOG2576; Eukaryota.
DR   eggNOG; ENOG410XPPM; LUCA.
DR   GeneTree; ENSGT00550000074967; -.
DR   HOGENOM; HOG000168174; -.
DR   HOVERGEN; HBG024332; -.
DR   InParanoid; Q9BVK2; -.
DR   KO; K03849; -.
DR   OMA; WKLKYPF; -.
DR   OrthoDB; EOG091G03DP; -.
DR   PhylomeDB; Q9BVK2; -.
DR   TreeFam; TF315002; -.
DR   BRENDA; 2.4.1.265; 2681.
DR   Reactome; R-HSA-446193; Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein.
DR   UniPathway; UPA00378; -.
DR   GeneWiki; ALG8; -.
DR   GenomeRNAi; 79053; -.
DR   PRO; PR:Q9BVK2; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000159063; -.
DR   CleanEx; HS_ALG8; -.
DR   ExpressionAtlas; Q9BVK2; baseline and differential.
DR   Genevisible; Q9BVK2; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IBA:GO_Central.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0000033; F:alpha-1,3-mannosyltransferase activity; IMP:UniProtKB.
DR   GO; GO:0042281; F:dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity; IBA:GO_Central.
DR   GO; GO:0004583; F:dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity; TAS:Reactome.
DR   GO; GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; TAS:Reactome.
DR   GO; GO:0006490; P:oligosaccharide-lipid intermediate biosynthetic process; IBA:GO_Central.
DR   GO; GO:0006487; P:protein N-linked glycosylation; IMP:UniProtKB.
DR   InterPro; IPR004856; Glyco_trans_ALG6/ALG8.
DR   PANTHER; PTHR12413; PTHR12413; 1.
DR   Pfam; PF03155; Alg6_Alg8; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome;
KW   Congenital disorder of glycosylation; Disease mutation;
KW   Endoplasmic reticulum; Glycosyltransferase; Membrane; Polymorphism;
KW   Reference proteome; Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN         1    526       Probable dolichyl pyrophosphate
FT                                Glc1Man9GlcNAc2 alpha-1,3-
FT                                glucosyltransferase.
FT                                /FTId=PRO_0000174162.
FT   TRANSMEM      4     24       Helical. {ECO:0000255}.
FT   TRANSMEM    103    122       Helical. {ECO:0000255}.
FT   TRANSMEM    143    163       Helical. {ECO:0000255}.
FT   TRANSMEM    188    208       Helical. {ECO:0000255}.
FT   TRANSMEM    238    258       Helical. {ECO:0000255}.
FT   TRANSMEM    334    354       Helical. {ECO:0000255}.
FT   TRANSMEM    368    388       Helical. {ECO:0000255}.
FT   TRANSMEM    389    409       Helical. {ECO:0000255}.
FT   TRANSMEM    427    449       Helical. {ECO:0000255}.
FT   TRANSMEM    461    481       Helical. {ECO:0000255}.
FT   TRANSMEM    488    508       Helical. {ECO:0000255}.
FT   VAR_SEQ     451    526       KEKPLFNWMETFYLLGLGPLEVCCEFVFPFTSWKVKYPFIP
FT                                LLLTSVYCAVGITYAWFKLYVSVLIDSAIGKTKKQ -> RS
FT                                FTLVAQAGVQWHDLS (in isoform 2).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_046291.
FT   VARIANT      47     47       T -> P (in CDG1H; dbSNP:rs121908293).
FT                                {ECO:0000269|PubMed:15235028}.
FT                                /FTId=VAR_023480.
FT   VARIANT     222    222       N -> S (in dbSNP:rs665278).
FT                                {ECO:0000269|PubMed:11124703,
FT                                ECO:0000269|PubMed:15235028}.
FT                                /FTId=VAR_023481.
FT   VARIANT     275    275       G -> D (in CDG1H; dbSNP:rs121908294).
FT                                {ECO:0000269|PubMed:15235028}.
FT                                /FTId=VAR_023482.
FT   VARIANT     439    439       I -> T (in dbSNP:rs17825668).
FT                                /FTId=VAR_031596.
FT   CONFLICT    478    478       F -> Y (in Ref. 1; CAA12176).
FT                                {ECO:0000305}.
FT   CONFLICT    503    503       I -> V (in Ref. 3; AAH01133).
FT                                {ECO:0000305}.
SQ   SEQUENCE   526 AA;  60088 MW;  71589A4EC09C3BE7 CRC64;
     MAALTIATGT GNWFSALALG VTLLKCLLIP TYHSTDFEVH RNWLAITHSL PISQWYYEAT
     SEWTLDYPPF FAWFEYILSH VAKYFDQEML NVHNLNYSSS RTLLFQRFSV IFMDVLFVYA
     VRECCKCIDG KKVGKELTEK PKFILSVLLL WNFGLLIVDH IHFQYNGFLF GLMLLSIARL
     FQKRHMEGAF LFAVLLHFKH IYLYVAPAYG VYLLRSYCFT ANKPDGSIRW KSFSFVRVIS
     LGLVVFLVSA LSLGPFLALN QLPQVFSRLF PFKRGLCHAY WAPNFWALYN ALDKVLSVIG
     LKLKFLDPNN IPKASMTSGL VQQFQHTVLP SVTPLATLIC TLIAILPSIF CLWFKPQGPR
     GFLRCLTLCA LSSFMFGWHV HEKAILLAIL PMSLLSVGKA GDASIFLILT TTGHYSLFPL
     LFTAPELPIK ILLMLLFTIY SISSLKTLFR KEKPLFNWME TFYLLGLGPL EVCCEFVFPF
     TSWKVKYPFI PLLLTSVYCA VGITYAWFKL YVSVLIDSAI GKTKKQ
//
